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ABSTRACT 
Increased antagonist muscle co-activation of the lower limb during walking seems to be an adaptive process to the 
physiological changes of aging, in order to gain joint stability. In the healthy subjects this view seems to be reinforced 
by the fact that the co-activation index (CAI) increases when the gait is faster. The few reports on antagonist co-
activation in Parkinson's disease (PD) patients indicate that they have larger co-activation than the healthy elderly, 
supporting the idea of the stabilization role of CAI during gait, as postural instability is a cardinal feature of PD. 
However it has also been reported that there is a reduction of the CAI when increasing velocity in PD or normal 
elderly. This questions the role of coactivation in stabilization during increased velocity. In this study we have 
analyzed the gait of healthy subjects (young and elderly), and PD patients (with and without freezing of gait, FOG) in 
order to better understand the relation between co-activation and gait kinematics, and to gain insight into the 
pathological changes associated with FOG in PD. We used Multiple Linear Regression models to study the 
relationship in shank muscles between CAI, velocity and cadence. Our results indicate that, for all groups of interest, 
the relationship between co-activation and the kinematics of gait is poor, due to the high degree of variability, 
questioning the explanatory value of the index. 
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1. Introduction 
Muscle co-activation has been studied for a better understanding of motor control of gait. From a 
theoretical point of view it seems that antagonist muscles in the lower limb should be activated 
sequentially, avoiding interference in their functions. However it is not clear whether this pattern 
represents the actual sequence of activation, even in healthy humans. In fact, an increase in antagonist co-
activation in the shank and thigh muscles, as a function of the gait velocity, has been reported 
(Hortobágyi et al., 2009; Schmitz et al., 2009). This suggests an adaptive process aimed at allowing 
greater stabilization around the joint (Peterson and Martin, 2010; Schmitz et al., 2009). This seems to be 
supported by the fact that aging can lead to loss of balance (Woollacott, 1993) and stability in gait 
(Hausdorff, 2007; Hausdorff et al., 2001). Therefore, the larger amount of co-activation displayed by the 
elderly for a given velocity might contribute to further increase the stability. However, this explanation 
has been recently challenged since the relationship between aging and increased co-activation of 
antagonist calf muscles has not been confirmed (Peterson and Martin, 2010). Insight on the role of 
antagonist muscle co-activation in gait can be gained by evaluating other populations with postural 
instability, such as people suffering from Parkinson's disease, but very few studies have evaluated this 
feature in PD during gait (Dietz et al., 1995). 
Experiments investigating EMG activity during gait in PD have provided intriguing results. In this 
case, co-activation in PD seems to follow a different pattern to the one mentioned before, and a reduction 
in the co-activation index while increasing velocity has been reported (it has also been obtained in healthy 
subjects when walking on a treadmill, Dietz et al., 1995). Interestingly, the study also indicated greater 
co-activation in the patient than in the healthy group for a given velocity, probably reflecting the above 
mentioned strategy to increase stability around the joint. It seems that a better understanding on the role 
of co-activation in gait in these two populations may be obtained by further analyzing different sub-types 
of subjects, for instance PD with freezing of gait (FOG). EMG analysis from patients suffering FOG 
revealed an alteration in the timing of discharge of antagonist muscles, tibialis anterior (TA) and 
gastrocnemius (GA), in the strides prior to the FOG episode (Nieuwboer et al., 2004). 
On the other hand, we reasoned that the evaluation of antagonist co-activation can be better achieved 
employing several variables instead of using only gait velocity. Velocity is just a relation between 
step/stride cadence and step/stride length which means that a given velocity can be obtained with a whole 
range of cadence/step length patterns, and so questioning if the co-activation index can be a useful 
parameter to characterize a given physiological or pathological gait pattern, if only related to one gait 
variable. 
This study is aimed to characterize the co-activation index in gait by examining its relationship to gait 
velocity and step cadence. We have evaluated different patterns of gait: physiological gait (young and 
elderly subjects), and pathological gait (advanced PD during ON-dose, and OFF-dose; with and without 
FOG). The group of patients, with marked postural instability during gait, was included because 
increasing CAI seems an adaptive process to gain joint stability while walking (Peterson and Martin, 
2010; Schmitz et al., 2009). Subjects were asked to walk in synchrony to a metronome beat. This 
approach has been useful to modulate a whole range of velocities, step lengths, and step cadences in a 
previous study (Arias and Cudeiro, 2008). 
2. Results 
2.1. Characterization 
Trochanteral height was comparable across groups, F(2,44)=0.376 p=0.689; there was however a 
main effect of age when comparing the groups F(2,44)=132.825 p<0.001; as expected post-hoc analysis 
showed that age of Young Control was significantly lower than that of Elderly and PD (p<0.001 in both 
cases); but Elderly Controls and PD were comparable in age (p=0.449). During preferred walking, CAI 
for the Young Controls was 0.32±0.04 (mean±SD), for the Elderly Controls was 0.41±0.06 and for the 
PD−FOGON group was 0.34±0.04. When walking as fast as posible the Young Controls were at 
0.34±0.06, the Elderly Controls 0.42±0.06 and the PD group 0.33±0.04. Due to safety concerns, the 
“walking as fast as possible” condition was avoided under OFF conditions and PD+FOG; for these 
groups during confort gait CAI was 0.35±0.09 for the PD−FOGOFF, 0.31±0.05 for the PD+FOGON and 
0.27±0.04 for the PD+FOGOFF. 
2.2. CAI is not influenced by walking in the presence of a metronome 
Firstly, one-way ANOVA showed the same behavior in all groups when compared with the 
CAIstimulated−unstimulated for a given cadence F(5,56)=1.80 p=0.128; for a given step length F(5,45)=0.40 
p=0.848; and for a given velocity F(5,41)=1.72 p=0.150. The lack of main effect of factor group in this 
analysis proved that the behavior was identical in all groups, therefore subsequent analysis was performed 
with all groups pooled. Subsequently our next approach was to seek if CAIstimulated−unstimulated was not 
significantly different from 0. The Student t-test for one simple showed that CAIstimulated−unstimulated was not 
significantly different from zero for all the variables analyzed, velocity t(46)=0.486 p=0.629, step length 
t(50)=1.090 p=0.281; and cadence t(62)=1.556 p=0.125 (Fig. 1). It is worth saying that lack of differences 
in stimulated vs. un-stimulated condition in the CAI for a given velocity, step length and cadence, is 
derived from a whole range of step lengths [0.27–1.37 m], cadences [1.04–2.22 steps/s], and velocities 
[0.44–2.66 m/s]. This reflects that the use of a metronome to modulate cadence, step length and velocity 
in a wide range does not make the CAI different from the one obtained in the same range in the absence 
of metronome.  
 Fig. 1 – The figure represents box and whisker plots for the difference between CAI in the absence and presence of auditory 
stimulation (the latter used in order to modulate gait), for a given step amplitude (m), a given cadence (steps/s), and a given velocity 
(m/s). Dots are outliers (values between 1.5 interquartile ranges (IQRs) and 3 IQRs from the end of a box), and asterisks represent 
extreme values (more than 3 IQRs from the end of a box). For each un-stimulated amplitude, cadence and velocity, a pair matched 
stimulated amplitude, cadence and velocity was selected, which was the closest stimulated within ±5% of the un-stimulated value. 
For each kinematic variable, once the pair-matched values were identified, their CAI was subtracted CAIunstimulated − stimulated which 
would be close to 0 in the case that the stimulated and un-stimulated conditions were the same. This would prove that the 
stimulation has no effect on the CAI regardless the gait pattern. Student t test for one sample proved that CAIunstimulated − stimulated was 
not statistically different from zero for a given amplitude t(50)=1.090 p=0.281, cadence t(62)=1.556 p=0.125 or velocity 
t(46)=0.486 p=0.629, therefore showing that the stimulation has no effect on CAI. 
2.3. CAI and its relation to kinematics 
Then, subsequent MLR analysis was performed to analyze whether CAI depends on velocity and 
cadence, and whether this relationship is different for different groups (young, elder, PD−FOGON&OFF, 
and PD+FOGON&OFF). For this purpose a total of 353 values were included in the regression analysis. 
MLR analysis predicts CAI for PD+FOGON=0.402−0.065·CADENCE PD+ FOGON + 0.031· 
VELOCITYPD+FOGON + 0.006·CAIYOUNG+ 0.009·CAIELDER − 0.040·CAIPD+FOGOFF + 0.035·CAIPD−FOGOFF 
+ 0.015. CAIPD − FOGON. However the most important result is provided by r2 which reflects the percentage 
of variability explained by the model. At this point a highly significant (p<0.001) coefficient of 
determination (r2=0.18) explains just 18% of the variability of the model (which reflects the relation of 
CAI with the different kinematics for the different groups), therefore questioning the validity of CAI 
during gait for characterizing gait patterns in the young, elder or PD (Figs. 2–4; see also Fig. 5). 
The above mentioned model accounts for inter-subject and inter-group variability. To describe intra-
subject (trial-to-trial) variability we performed another MLR analysis. The analysis was applied including 
the factor subject (rather than the factor group). In a first instance the rest of the explanatory variables (i.e. 
cadence, velocity) were maintained.  
 Fig. 2 – The figure represents the relation of one of the 
kinematic variables (cadence) included in the MLR analysis 
with CAI. Results from the MLR analysis proved that just 18% 
of the variability can be explained by the model, some other 
approaches different to linear relations have been also used. 
These results therefore mean that CAI cannot be successfully 
explained by cadence (or velocity — see Fig. 3), which can 
easily be seen in the plot. This was observed in all groups of 
interest (young, elder, and PD), since the MLR results showed 
identical behavior in all groups. This, therefore, questions the 
validity of CAI being explained just by the kinematics in order 
to characterize gait in PD, elderly, or young subjects. 
 
This way the variability explained by the model increases (r2=0.82; p<0.001). However the increment 
in the predictive value of the model is not due to the relation between the kinematics (velocity and 
cadence) and CAI. A subsequent exclusión of the kinematics as explanatory variables barely reduces the 
predictive value (r2=0.78; p<0.001) of the model. The equations were left out to increase clarity (as they 
include more than 48 and 46 independent variables). The results reinforce the poor relation between the 
kinematics and CAI and show that every subject has a quite defined CAI poorly affected by the different 
gait patterns performed. 
 
Fig. 3 – The figure represents the relation of another kinematic 
variable (velocity) included in the MLR analysis with CAI. The 
same trend as explained in the legend of Fig. 2 for the relation 
cadence vs. CAI is observed for the relation velocity vs. CAI. 
 
 
Fig. 4 – This figure depicts the predicted values of CAI using 
the multivariate linear fit versus the observed CAI values. The 
diagonal straight line accounts for perfect prediction. As it can 
be clearly observed in the figure, the dispersion of the point 
cloud around the diagonal line is large. Thus, the amount of 
variability of CAI that can be explained by the linear model is 
low (just 18%, according to r2=0.18). 
 
 
 
  
 Fig. 5 – The figure represents a sequence of strides of an elder control separated by vertical dotted lines with their CAI. Strides were 
identified by means of footswitches (line at the bottom). Raw EMG activity is represented with an offset to clearly identify both 
upper (TI) and lower (SO) muscles. Kinematics (C—cadence, A—amplitude, V—velocity) and CAI at the upper part of the graph 
are mean values for two different recordings on the same subject. This figure further explains the poor relation between the CAI and 
the kinematics. Equivalent levels of the CAI (26% and 25%) are obtained with different velocities (70.2 and 61.2 m/min). This 
clearly reinforces results from Fig. 3 that represent high variability in the relationship between CAI and kinematics. 
3. Discussion 
This works shows that antagonist muscle co-activation of TI and SO during straight gait patterns in 
different sets of subjects, displaying physiological (young and elderly) and pathological (parkinsonian) 
gait, presents high variability, not successfully explained by kinematics. 
The analysis of antagonist CAI during gait has been chiefly focused on the study of physiological 
aging (Hortobágyi et al., 2009; Peterson and Martin, 2010; Schmitz et al., 2009) and on some pathologies 
like stroke (Lamontagne et al., 2000), or knee osteoarthritis (Hubley-Kozey et al., 2009). Some of the 
above mentioned studies, and others (for example, Mian et al., 2006), evaluated CAI on thigh muscles. 
While the evaluation of thigh muscles is reasonable for the study of knee pathologies (Hubley-Kozey et 
al., 2009), it excludes shank muscles (with no direct role on knee functioning, i.e. tibialis anterior). 
Conversely, we have focused on distal muscles, at which specific EMG-profiles have been shown in 
subjects with marked postural instability (PD; and in advance to FOG, Nieuwboer et al., 2004). 
In the case of elderly some studies have provided conflicting results when trying to relate 
physiological aging to an increase in the CAI, and increments and decrements in the CAI in shank 
muscles when increasing velocity have been reported (Dietz et al., 1995; Hortobágyi et al., 2009; Peterson 
and Martin, 2010). One basic element to understand the increase in CAI when increasing velocity is to 
gain joint stability (Schmitz et al., 2009), and therefore aging, which is related to impairment in balance 
(Woollacott, 1993), would further increase the need for larger CAI. We meant to understand this point by 
reviewing literature on diseases impairing balance, like PD, but the relation between gait and antagonist 
CAI became further complex. Dietz et al. (1995) reports greater CAI in shank muscles for PD than for 
healthy, which can be deemed as adaptive processes in order to gain joint stability when walking. 
However the same work shows both PD and healthy to reduce CAI when increasing velocity (Dietz et al., 
1995). 
The topic is of interest because if a clear relationship between antagonist CAI and gait patterns can be 
elucidated it would help to explain gait disturbances in pathological population. For instance, FOG in PD 
has been reported to be advanced by an altered discharge of antagonist shank muscles while walking 
(Nieuwboer et al., 2004); therefore determining if CAI in PD freezers presents a characteristic profile 
might help to differentially advance the prognosis of gait-related disturbances in the disease. 
However, when conceiving our study, we clearly thought that the relation of CAI to gait should not 
only be explained by its simple relation to velocity; it is clear that a given velocity can be achieved with a 
whole range of different gait patterns (for instance combinations of different patterns of cadence and step 
length). Therefore when we analyzed CAI in the different populations in relation to velocity and cadence, 
a more clear depiction of the topic emerged in all populations. Our results comparing subject and groups 
explain that a given CAI can be displayed with many gait patterns; as the analysis clearly shows that CAI 
presents a high level of variability very poorly explained by cadence, and velocity in all the groups 
studied. Therefore data from different studies, which could be thought as difficult to match – for instance 
reduction in CAI when increasing velocity in PD and healthy (Dietz et al., 1995) vs. increase in CAI 
when increasing velocity in elderly – can just simply be the result of the variability of that relation. On the 
other hand, variability in the gait related EMG activity is not a new issue: inter-individual variability 
(Shiavi et al., 1981), or inter-group variability specifically in the groups of interest of the present study 
(Miller et al., 1996), has been demonstrated. Our results showed no differential effect for the level of 
variability in the relation CAI vs. any of the kinematics for the different groups; so that no defined 
association can be established between CAI and kinematics for any group. Intra-individual variability 
includes stride-to-stride variability (Burden et al., 2003), which reflects different CAIs for subsequent 
strides (see Fig. 5 for individual stride-CAIs), and also trial-to-trial CAI variability. While evaluation of 
stride-to-stride-CAI in relation to kinematics would need both stride-to-stride velocity and stride-to-stride 
cadence (or amplitude), trial-to-trial variability of CAI vs. kinematics is explained by our second MLR. 
This shows a defined pattern of CAI for each of the different subjects (accounting for nearly 80% of 
variability of CAI), with a very small value added if related to the kinematics (velocity and cadence). 
Then, clearly, the physiological meaning of CAI variability is an issue which must be further studied, 
since while EMG gait-related variability, in the temporal (and amplitude) domains, might be associated 
with postural instability, it might also be tied to feed-back adaptability, allowing steady onwards motion 
(Miller et al., 1996). Our study, then, provides insight on an issue (the variability of CAI in relation to 
kinematics) which might in previous studies have been misinterpreted or simply passed unnoticed. 
Possibly, in the future, studies controlling the 3 variables included in the relation “Velocity=Stride 
Length×Stride Cadence” would help to show a more clear profile of CAI in its relation to kinematics in 
subjects with different levels of postural instability — cued-treadmill walking would allow this design. 
This proposal will also allow evaluation of stride-to-stride CAI variability in relation to stride-to-stride 
velocity, cadence and amplitude variability (since all of them would be controlled). Notwithstanding, it is 
clear that results from this study do not question the results for other pathologies at which a more defined 
pattern seems to have been described, for instance in knee osteoarthritis (Hubley-Kozey et al., 2009) or 
stroke (Lamontagne et al., 2000). 
In conclusion, antagonist CAI in healthy controls and PD during gait gives rise to high variability in 
relation to the kinematic profile such that, to date, it does not clearly explain physiological or pathological 
gait profiles in these populations; further designs are needed in order to clarify the relation between CAI 
and kinematics. 
4. Experimental procedures 
4.1. Subjects 
47 subjects were recruited for this study; 7 young; 20 elderly; 20 PD in stages III–IV of the Hoehn and 
Yahr scale (Hoehn and Yahr, 1967). Subjects presented lack of un-correctable auditory–visual 
impairment, lack of musculoskeletal injury, and scored >24 points in Mini Mental Examination Score 
(Folstein et al., 1975) when checking cognitive impairment. 
4.1.1. Young controls 
Young healthy students were recruited for the study. Their trochanteral height was 0.89m (±0.06); and 
their age was 21.86 yrs (±1.46). 
4.1.2. Elderly controls 
Healthy subjects working in our institution (or their relatives) were selected as the Elderly Control 
group, age 66.60 yrs (±7.78), trochanteral height 0.87m (±0.05). 
Both control groups of healthy subjects were screened for any possible history of neurological or 
psychiatric disorder before the experimental session (interview, MMSE, pull-test). All healthy subjects 
scored 0 in a pull-test (UPDRS) performed prior to the experimental session; none of them was receiving 
neuroactive drugs during the week prior to the test.  
4.1.3. Patients 
Patients belonged to the Association Parkinson Galicia and were approached through the association's 
neurologist. Patients included in this study were 68.25 yrs (±6.85), and their trochanteral height was 
0.88m (±0.07). Seven out of 16 patients without history of FOGwere evaluated duringON-dose period 
(i.e. at the moment when antiparkinsonian medication produced its best effect — PD−FOGON); and the 
other 6 while OFF-dose (i.e. in the absence of antiparkinsonian medication, moment at which 
parkinsonian signs are displayed with greatest severity — PD−FOGOFF). All patients with history of FOG 
were evaluated during both ON and OFF doses, (PD+FOGON) and (PD+FOGOFF), respectively. 
4.1.3.1. PD+FOG. Patients in this group, who exhibited significant FOG, had to match the following 
criteria: 
 
• diagnosis of idiopathic PD based on the UK Parkinson's Disease Society Brain Bank for clinical 
diagnostic criteria (Hughes et al., 1992) 
• history of freezing during walking, confirmed from medical records, and score>10 (and ≥2 in item #3) 
in the Freezing of Gait Questionnaire (FOGQ) (Giladi et al., 2000) 
• predictable motor fluctuation related to dose intake, determined from medical records and neurological 
examination 
• at the moment of testing, they should be able to walk 6 m unaided, turn around and come back, despite 
the freezing episodes at turning or start walking. Given the nature of this study patients suffering from 
FOG during the straight part of the task were excluded from the analysis. 
4.1.3.2. PD−FOG. PD without history of FOG were also recruited. Inclusion criteria were the same as 
stated for PD+FOG, with the exception of those criteria related to FOG. The score in the FOGQ had to be 
zero to be a possible subject in this group. 
4.2. Procedure 
Subjects walked along a straight walkway 6m long until 24m is completed. Data from turns at the end 
of the walkway were not analyzed given that our objective was to analyze the relation of co-activation to 
straight gait parameters. 
4.2.1. Walking conditions 
Initially subjects had to walk at their preferred walking (PW) cadence for the first 24 m. In the next 
condition subjects were asked to walk as fast as possible (FW). Afterwards, and in order to modulate gait 
velocity, cadence and step length, subjects were asked to walk matching their steps to a metronome, 
which was set at different percentages of each subject's fast walking cadence (from 50 to 110% FW-
cadence; order of presentation was randomized). This procedure has been shown tomodulate gait patterns 
in advance PD without freezing, and in healthy controls (Arias and Cudeiro, 2008); a stimulation 
condition including a frequency matching PW cadence was also included. 
In the case of PD+FOG and PD−FOGOFF the stimulation conditions and their number were modified 
given the unability shown by the subjects to walk safely in the fast walk condition, and also because of 
the troublesome gait displayed during the slowest stimulation frequencies. Therefore these patients were 
asked to walk at their preferred un-stimulated cadence and also in the presence of a metronome 10 and 
20% faster than the PW cadence. Having into account the previous data that shows that auditory 
stimulation matching PW cadence induces gait patterns with lower cadence tan un-stimulated PW 
cadence (Arias and Cudeiro, 2008), this condition was included in order to modulate cadence downwards. 
12 of the healthy controls performed only this protocol in order to match controls for the different subsets 
of PD's protocols. The protocol was bound to the Helsinki declaration and approved by our institution's 
ethics committee; subjects signed consent forms. 
4.3. Material 
4.3.1. EMG and kinematic recordings 
Biometrics DataLog (Biometrics Ltd, Gwent, UK) was utilized for EMG recordings sampled at 1 
kHz; bipolar surface electrodes were placed bilaterally over tibialis anterior (TI) and soleus (SO) muscles 
following standard procedures (Cram et al., 1998). Probe skin electrodes (Biometrics SX230) included 
preamplifiers (gain 1000) and low/high pass (20–450 Hz) were place over the muscles. Skin preparation 
included shaving, abrading and cleaning with alcohol; EMG gel was applied over the poles of the 
electrode in order to reduce impedance to the minimum level. Adhesive pads were fixed to the electrode 
and then bilaterally to the skin. The ground electrode was placed over the wrist. Contact footswitches 
were integrated by means of the digital channels of the DataLog System, which was synchronized to the 
photocells allowing registration of feet contact; sampling rate for each pair of footswitch was sampled at 
1 kHz. Data was stored for detailed OFF-line analysis using customized programs implemented in 
MatLab. 
4.4. Data processing 
EMG recordings for each muscle were processed including full-wave rectification and averaging with 
a sample-time constant of 10ms, and normalization in amplitude. Age-related sensorimotor impairment 
leads to activation deficit during MVC (Stevens et al., 2003), and this is maximized in PD due to deficits 
in kinesthesia (Klockgether et al., 1995) (i.e. PD+FOGOFF was hardly capable of recruiting soleus muscle 
during MVC against an external load). Therefore, we normalized EMG activity taking as reference peak 
amplitude during baseline gait. This is in line with works avoiding the use of maximal voluntary 
contraction (MVC) for normalizing EMG-activity in elder or PD in different movements, including gait 
(Caliandro et al., 2011; Murley et al., 2010; Peterson and Martin, 2010; Powell et al., 2011). The 
coactivation index (CAI)was calculated following the equation described by Winter (1990), for which a 
minimum of 16 strides were analyzed in each subject, which were identified through footswitches 
recordings (Fig. 5): 
 
CAI = 2 · (∫ min{EMGi(t), EMGj(t)}dt/ ∫ (EMGi(t)dt + EMGj(t)dt)) 
       (1) 
 
The numerator of the equation reflects the amount of overlapping activity (common area) from both 
muscles EMGi and EMGj (TA and SO), divided by the sum of both areas. 
All the 7 PD+FOG displayed freezing during the whole walking task but in all of them FOG appeared 
when turning or starting walking, which are by far the most frequent types of FOG (Arias and Cudeiro, 
2010; Giladi et al., 1992); recordings from turning were not included into the analysis. 
4.5. Analyzed variables 
Variables of interest were: 
 
CAI calculated as mentioned before (see Eq. 1). Given PD displayed bilateral affectation (stage III–IV 
Hoehn and Yahr), the average of both legs was used, following the same procedure as for healthy. 
Velocity calculated from the distance covered and the time (achieved through photocells) needed to 
complete the distance, expressed in m/s. 
Cadence number of steps/s, calculated from footswitches data. 
Step length derived as a function of velocity and cadence, expressed in m. 
4.6. Statistical analysis 
Our first approach to the statistical analysis was to evaluate a possible effect of the auditory 
stimulation (strategy used to modulate kinematics of gait) on modifying CAI with respect to un-
stimulated gait in all groups. Thus, for each of the kinematic variables (cadence, step length, and velocity) 
we matched the un-stimulated condition (PW or FW) to the closest stimulation condition (if any) within a 
range of ±5% of the un-stimulated one. Thus, if one subject cadence was 100 steps/min in one un-
stimulated condition, it was looked for the closest cadence in the presence of stimulation within the range 
defined (95–105 steps/min; in this case); the same for step length and velocity. Subsequently, for each 
pair-matched value the difference in their CAI (CAI in the stimulated condition minus the CAI in the un-
stimulated condition) was calculated (CAI stimulated − unstimulated). Then, to know if this relation depends on 
group, a one-way ANOVA was performed with Group as main factor for the CAIstimulated − unstimulated. 
Therefore if the group effect is not statistically significant we assume the behavior of all groups to be the 
same (for each variable). So we performed further statistical analysis with all groups pooled. 
Subsequently, the CAIstimulated − unstimulated was used to know if the auditory stimulation modifies the CAI 
for a given gait pattern, which in case of not being affected by stimulation will tend to be 0 for each pair 
stimulated/un-stimulated. This was checked by applying a one-sample Student t-test setting 0 as the 
reference value, therefore lack of statistical difference would mean there is no difference in the stimulated 
vs. un-stimulated condition for a given value (of cadence, step length, and velocity). Since the test was 
not significant for all the assumptions lack of effect of stimulation over CAI is confirmed. 
Then, in order to characterize CAI gait pattern for each group, and its relation to cadence, step length, 
and velocity, Multiple Linear Regression (MLR) analysis was performed, setting the CAI as the 
dependent variable, and the variables Group (young, elder, PD−FOGON, PD−FOGOFF, PD+FOGON, 
PD+FOGOFF), Cadence, and Velocity, as explanatory variables, therefore predicting the relation of CAI to 
the different kinematics, and explaining the inter-subject and inter-group variability. 
Step length was left out of the model given that the included variables must not be directly dependent. 
Since there exists a direct relation between velocity cadence and step length, and because velocity and 
cadence were included as explanatory variables, step length was the one left out. This was selected given 
that the relation between Velocity and CAI is of interest considering the background provided by 
literature, and Cadence is also of interest since the stimulation proposed aimed to match step cadence. 
Subsequently the same model was applied again to evaluate intra-subject (trial to trial) variability. In a 
first instance for this purpose the dependent variable was the same CAI, and the explanatory variables 
were Cadence, Velocity, and Subject (rather than Group). Afterwards, the analysis was performed again, 
but leaving out the kinematic variables as explanatory variables to understand its impact on the CAI. 
Data was analyzed using Statgraphics. Normality was assessed by Kolmógorov–Smirnov test, and 
heteroscedasticity was checked using Durwin–Watson test. Significance was set at 0.05. 
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